AAIC 2025 Abstract
SPEAR UltraDetect™ pTau‐217: A High‐Accuracy, Scalable Plasma Biomarker for PET Confirmed Cognitively Impaired Patients Using a Single Cutoff
Study in peopleBiomarkers
Abstract
Background: Alzheimer's disease misdiagnosis in specialized clinics and primary care often delays confirmatory testing and treatment windows for anti‐amyloid therapies.
